col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


28 Results       Page 1

 [1] 
Wiley: Pharmacoepidemiology and Drug Safety
  original article Date Title Authors   All Authors
1 [GO] 2024―Nov―26 Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals Ella van Vliet, Nanča Čebron Lipovec, Marloes van der Goot, Shahab Abtahi, Inês Ribeiro -Vaz, Elita Poplavska, et al. (+13)
2 [GO] 2024―Nov―13 Investigating the Safety Profile of Fast-Track COVID-19 Drugs Using the FDA Adverse Event Reporting System Database: A Comparative Observational Study Hyo Jung Kim, Jeong-Hwa Yoon, Kye Hwa Lee
3 [GO] 2024―Oct―25 Validation Study of the Claims-Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study Taku Chikamochi, Chieko Ishiguro, Wataru Mimura, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
4 [GO] 2024―Oct―18 Dexamethasone Dose for COVID-19 in a Large U.S. Hospital Network From April 2020 to May 2023 Marie C. Bradley, Ashish Rai, Austin Cosgrove, Silvia Perez-Vilar, Candace Fuller, Edward Rosen, et al. (+6)
5 [GO] 2024―Oct―08 Validation Assessment of Privacy-Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real-World COVID-19 Vaccine Effectiveness Echo Wang, Katrina Mott, Hongtao Zhang, Sivan Gazit, Gabriel Chodick, Mehmet Burcu
6 [GO] 2024―Aug―18 Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink Thomas G. Boyce, David L. McClure, Kayla E. Hanson, Matthew F. Daley, Malini B. DeSilva, Stephanie A. Irving, et al. (+8)
7 [GO] 2024―Aug―13 A Dynamic Prognostic Model for Identifying Vulnerable COVID-19 Patients at High Risk of Rapid Deterioration Priyanka Anand, Elvira D'Andrea, William Feldman, Shirley V. Wang, Jun Liu, Gregory Brill, et al. (+2)
8 [GO] 2024―Aug―05 Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C) Xuya Xiao, G. Caleb Alexander, Hemalkumar B. Mehta
9 [GO] 2024―Aug―02 Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational Studies Frank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski
10 [GO] 2024―Apr―03 Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpoints Candace C. Fuller, Edward Rosen, Ashish Rai, Austin Cosgrove, Karla Miller, Patricia Bright, et al. (+9)
11 [GO] 2023―Nov―10 The risk of miscarriage after COVID-19 vaccination before and during pregnancy Maud de Feijter, Marleen M. H. J. van Gelder, Lieke C. M. Vissers, Agnes C. Kant, Petra J. Woestenberg
12 [GO] 2023―Sep―16 Altered liver function test after Covid-19 vaccines: A retrospective control group study Fernando Ezequiel Jabif, Marcelo Gabriel Vallone, Vanina Cecilia Stanek, Marlene Padilla Lopez, Natalia Sobenko, Alejandra Maria Villamil, Maria Florencia Grande Ratti
13 [GO] 2022―Nov―10 Understanding the variability of pharmaco-epidemiological studies assessing the risk of appendicitis with mRNA COVID-19 vaccines Clement Jambon-Barbara, Claire Bernardeau, Jean-Luc Cracowski, Charles Khouri
14 [GO] 2022―Nov―05 Social Media for Early Characterization of Pandemic Symptoms: A Qualitative Analysis of Patient-Reported COVID -19 experiences Melissa Khashei, Scott Janiczak, Christopher St. Clair, Wei Liu, Jae Joon Song, Wei Hua, et al. (+2)
15 [GO] 2022―Sep―20 Anti-Osteoporosis Medication dispensing by Clinical Commissioning Groups in England - an ecological study of variability in practice and of the effect of the Covid-19 pandemic S. S. Janjua, H. F. Boardman, A. Sami, A. Johansen, L. S. Toh, M. K. Javaid
16 [GO] 2022―Sep―16 Telemedicine Use Among Patients With Metastatic Breast Cancer During the COVID-19 Pandemic: Differences by Race, Age and Region Gregory S. Calip, Aaron Cohen, Rebecca Rohrer, Xiaoliang Wang, Xiaoyan Wang, Amy We, et al. (+4)
17 [GO] 2022―Aug―23 A Systematic Review of Whether COVID-19 Randomized Controlled Trials Reported on Demographic and Clinical Characteristics Joyce Pak, Jennifer L. Lund, Alexander Keil, Daniel Westreich, Til Stürmer, David Wohl, et al. (+3)
18 [GO] 2022―Aug―10 Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: reports to the Vaccine Adverse Event Reporting System Emily Jane Woo, Adamma Mba-Jonas, Alisha Thomas, Bethany Baer, Brendan Day, Yeowon Kim, et al. (+2)
19 [GO] 2022―Jul―06 Comparison of Drug Prescribing Before and During the COVID -19 Pandemic - A Cross-national European Study Iva Selke Krulichová, Gisbert W. Selke, Marion Bennie, Mohammadhossein Hajiebrahimi, Fredrik Nyberg, Jurij Fürst, et al. (+14)
20 [GO] 2022―May―15 Myopericarditis following COVID-19 mRNA vaccination Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
21 [GO] 2022―Apr―23 International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID -19 pandemic: A cross-sectional analysis of 66 countries Tara Gomes, Katherine Callaway Kim, Katie J. Suda, Ria Garg, Mina Tadrous
22 [GO] 2022―Apr―15 COVID -19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy ( IRCEP ) Whitney J. Westhoff, Louisa H. Smith, Diego F. Wyszynski, Sonia Hernandez-Diaz
23 [GO] 2022―Mar―17 Pandemic vaccine testing: combining conventional and challenge studies Tobias Gerhard, Brian L. Strom, Nir Eyal
24 [GO] 2021―Dec―09 SARS-CoV -2 vaccine-related adverse events in Zimbabwe: the need to strengthen pharmacovigilance in resource-limited settings Grant Murewanhema, Tafadzwa Dzinamarira, Roda Madziva, Helena Herrera, Godfrey Musuka
25 [GO] 2021―Jul―10 Utilization of drugs with reports on potential efficacy or harm on COVID -19 before, during, and after the first pandemic wave Salka Enners, Gabriele Gradl, Marita Kieble, Michael Böhm, Ulrich Laufs, Martin Schulz
26 [GO] 2021―Mar―27 QTc prolongation in COVID-19 patients treated with Hydroxychloroquine, Chloroquine, Azithromycin, or Lopinavir/Ritonavir: A systematic review and meta-analysis Carlos Diaz-Arocutipa, Ana Brañez-Condorena, Adrian V. Hernandez
27 [GO] 2021―Mar―02 Global COVID -19 Pandemic and Reporting Behavior - An Analysis of the Food and Drug Administration Adverse Events Reporting System ( FAERS ) Michael Dörks, Kathrin Jobski, Falk Hoffmann, Antonios Douros
28 [GO] 2020―May―05 Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic# Anton Pottegård, Xavier Kurz, Nicholas Moore, Christian F. Christiansen, Olaf Klungel
 [1] 

28 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec